Abstract
Secondary hypertension, where a treatable underlying cause can be identified, is reported to be about 10% of all diagnosed hypertension. Treating the underlying condition can improve or cure hypertension. An increased prevalence is seen in patients with resistant hypertension, hypokalemia, and younger patients. Common causes of secondary hypertension also include renovascular and renal parenchymal disease, and primary aldosteronism.
Other conditions including pheochromocytoma, Cushing’s Syndrome, and coarctation of the aorta are less frequent causes of secondary hypertension. Obstructive sleep apnea is common and is associated with hypertension. Increased awareness and early diagnosis with targeted treatment significantly improves outcomes for patients diagnosed with secondary hypertension.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
An overview of hypertension and cardiac involvement in Asia: focus on heart failure. [cited 2021 Jun 11]. https://onlinelibrary.wiley.com/doi/10.1111/jch.13753.
Venketasubramanian N, Yoon BW, Pandian J, Navarro JC. Stroke epidemiology in South, East, and South-East Asia: a review. J Stroke. 2017;19(3):286–94.
Liew SJ, Lee JT, Tan CS, Koh CHG, Van Dam R, Müller-Riemenschneider F. Sociodemographic factors in relation to hypertension prevalence, awareness, treatment and control in a multi-ethnic Asian population: a cross-sectional study. BMJ Open. 2019;9(5):e025869.
Lu J, Lu Y, Wang X, Li X, Linderman GC, Wu C, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study (China PEACE Million Persons Project). Lancet. 2017;390(10112):2549–58.
Hirsch JS, Hong S. The demystification of secondary hypertension: diagnostic strategies and treatment algorithms. Curr Treat Options Cardiovasc Med. 2019;21(12):90.
Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T. Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res. 2004;27(3):193–202.
Mancia G, Rosei EA, Azizi M, Burnier M, Clement DL, Coca A, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. 98.
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines [Internet]. [cited 2021 Jun 20]. https://www.ahajournals.org/doi/epub/10.1161/HYP.0000000000000065.
2018 Chinese guidelines for prevention and treatment of hypertension—a report of the Revision Committee of Chinese guidelines for prevention and treatment of hypertension. J Geriatr Cardiol. 2019;16(3):182–241.
Resistant hypertension: diagnosis, evaluation, and treatment [Internet]. [cited 2021 Jun 20]. https://www.ahajournals.org/doi/epub/10.1161/CIRCULATIONAHA.108.189141.
Guillaume L, Mathieu A, Mélanie D, Nicolas B-C, Nantes University Hospital Working Group on Hypertension. Resistant hypertension: novel insights. Curr Hypertens Rev. 2020;16(1):61–72.
Kvapil T, Vaclavik J, Benesova K, Jarkovsky J, Kocianova E, Kamasova M, et al. Prevalence of secondary hypertension in patients with resistant arterial hypertension. J Hypertens. 2021;39:e357.
Burrello J, Monticone S, Losano I, Cavaglia’ G, Buffolo F, Tetti M, et al. Prevalence of primary aldosteronism and hypokalemia in 5,100 patients referred to a tertiary hypertension unit. J Hypertens. 2021;39:e61.
Rimoldi SF, Scherrer U, Messerli FH. Secondary arterial hypertension: when, who, and how to screen? Eur Heart J. 2014;35(19):1245–54.
Puar T, Mok Y, Debajyoti R, Khoo J, How C, Ng A. Secondary hypertension in adults. Singapore Med J. 2016;57(05):228–32.
Chapter 13. Secondary hypertension. Hypertens Res. 2014;37(4):349–61.
Williams GJ, Macaskill P, Chan SF, Karplus TE, Yung W, Hodson EM, et al. Comparative accuracy of renal duplex sonographic parameters in the diagnosis of renal artery stenosis: paired and unpaired analysis. AJR Am J Roentgenol. 2007;188(3):798–811.
Vasbinder GBC, Nelemans PJ, Kessels AGH, Kroon AA, Maki JH, Leiner T, et al. Accuracy of computed tomographic angiography and magnetic resonance angiography for diagnosing renal artery stenosis. Ann Intern Med. 2004;141(9):674–82; discussion 682.
Stenting and medical therapy for atherosclerotic renal-artery stenosis | NEJM [Internet]. [cited 2021 Jun 15]. https://www.nejm.org/doi/full/10.1056/nejmoa1310753.
Chrysochou C, Foley RN, Young JF, Khavandi K, Cheung CM, Kalra PA. Dispelling the myth: the use of renin-angiotensin blockade in atheromatous renovascular disease. Nephrol Dial Transplant. 2012;27(4):1403–9.
Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metabol. 2016;101(5):1889–916.
Milliez P, Girerd X, Plouin P-F, Blacher J, Safar ME, Mourad J-J. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol. 2005;45(8):1243–8.
Catena C, Colussi G, Lapenna R, Nadalini E, Chiuch A, Gianfagna P, et al. Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism. Hypertension. 2007;50(5):911–8.
Mulatero P, Stowasser M, Loh K-C, Fardella CE, Gordon RD, Mosso L, et al. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metabol. 2004;89(3):1045–50.
Newell-Price J, Bertagna X, Grossman AB, Nieman LK. Cushing’s syndrome. Lancet. 2006;367(9522):1605–17.
Diagnosis of Cushing’s syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. Oxford Academic [Internet]. [cited 2021 Jun 15]. https://academic.oup.com/jcem/article/93/5/1526/2598096.
Meifen Z, Zainudin SB, Ling CC. Pheochromocytoma crisis triggered by extra-corporal membrane oxygenation explanation. J Adv Med Med Res. 2016:1–5.
Lo CY, Lam KY, Wat MS, Lam KS. Adrenal pheochromocytoma remains a frequently overlooked diagnosis. Am J Surg. 2000;179(3):212–5.
Young WF. Adrenal causes of hypertension: pheochromocytoma and primary aldosteronism. Rev Endocr Metab Disord. 2007;8(4):309–20.
Arar MY, Hogg RJ, Arant BS, Seikaly MG. Etiology of sustained hypertension in children in the southwestern United States. Pediatr Nephrol. 1994;8(2):186–9.
Weber HS, Cyran SE. Endovascular stenting for native coarctation of the aorta is an effective alternative to surgical intervention in older children. Congenit Heart Dis. 2008;3(1):54–9.
Pedrosa RP, Drager LF, Gonzaga CC, Sousa MG, de Paula LKG, Amaro ACS, et al. Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension. Hypertension. 2011;58(5):811–7.
Hou H, Zhao Y, Yu W, Dong H, Xue X, Ding J, et al. Association of obstructive sleep apnea with hypertension: a systematic review and meta-analysis. J Glob Health. 2018;8(1):010405.
Logan AG, Perlikowski SM, Mente A, Tisler A, Tkacova R, Niroumand M, et al. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens. 2001;19(12):2271–7.
Tan A, Cheung YY, Yin J, Lim W-Y, Tan LWL, Lee C-H. Prevalence of sleep-disordered breathing in a multiethnic Asian population in Singapore: a community-based study. Respirology. 2016;21(5):943–50.
The-AASM-Manual-for-Scoring-of-Sleep-and-Associated-Events-2007-.pdf [Internet]. [cited 2021 Jun 16]. https://www.sleep.pitt.edu/wp-content/uploads/2020/03/The-AASM-Manual-for-Scoring-of-Sleep-and-Associated-Events-2007-.pdf.
Young T, Skatrud J, Peppard PE. Risk factors for obstructive sleep apnea in adults. JAMA. 2004;291(16):2013–6.
Screening tools for the obstructive sleep apnea for the cardiovascular clinician [Internet]. American College of Cardiology. [cited 2021 Jun 20]. https://www.acc.org/latest-in-cardiology/articles/2015/07/14/11/04/http%3a%2f%2fwww.acc.org%2flatest-in-cardiology%2farticles%2f2015%2f07%2f14%2f11%2f04%2fscreeing-tools-for-the-obstructive-sleep-apnea-for-the-cardiovascular-clinician.
Chung F, Abdullah HR, Liao P. STOP-Bang Questionnaire: a practical approach to screen for obstructive sleep apnea. Chest. 2016;149(3):631–8.
Giles TL, Lasserson TJ, Smith BJ, White J, Wright J, Cates CJ. Continuous positive airways pressure for obstructive sleep apnoea in adults. Cochrane Database Syst Rev. 2006;(1):CD001106.
Bratton DJ, Gaisl T, Wons AM, Kohler M. CPAP vs mandibular advancement devices and blood pressure in patients with obstructive sleep apnea: a systematic review and meta-analysis. JAMA. 2015;314(21):2280–93.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Zhang, M., Wong, H.S., Malakar, R.D., Puar, T.H. (2022). Secondary Causes of Hypertension: An Overview. In: Ram, C.V.S., Teo, B.W.J., Wander, G.S. (eds) Hypertension and Cardiovascular Disease in Asia. Updates in Hypertension and Cardiovascular Protection. Springer, Cham. https://doi.org/10.1007/978-3-030-95734-6_15
Download citation
DOI: https://doi.org/10.1007/978-3-030-95734-6_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-95733-9
Online ISBN: 978-3-030-95734-6
eBook Packages: MedicineMedicine (R0)